Vlad K Kumirov Selected Research

mu Opioid Receptors (mu Opioid Receptor)

12/2013

Novel fentanyl-based dual μ/δ-opioid agonists for the treatment of acute and chronic pain.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Vlad K Kumirov Research Topics

Disease

2	Chronic Pain 02/2023 - 12/2013
2	Pain (Aches) 01/2017 - 12/2013
2	Neuralgia (Stump Neuralgia) 01/2017 - 12/2013
1	Constipation 02/2023
1	Opioid-Related Disorders (Opiate Addiction) 02/2023
1	Respiratory Insufficiency (Respiratory Failure) 02/2023
1	Neoplasms (Cancer) 01/2023
1	Frontotemporal Lobar Degeneration (Degeneration, Frontotemporal Lobar) 01/2019

Drug/Important Bio-Agent (IBA)

3	Opioid Analgesics (Opioids)IBA 02/2023 - 12/2013
2	Analgesics (Analgesic Drugs)IBA 02/2023 - 01/2017
2	Fentanyl (Sublimaze)FDA LinkGeneric 01/2017 - 12/2013
1	Hormones (Hormone)IBA 02/2023
1	Oxytocin (Pitocin)FDA LinkGeneric 02/2023
1	Hyaluronic Acid (Hyaluronan)IBA 01/2023
1	Proteins (Proteins, Gene)FDA Link 01/2019
1	Opioid Receptors (Opioid Receptor)IBA 01/2017
1	EnkephalinsIBA 01/2017
1	Peptides (Polypeptides)IBA 01/2017
1	LigandsIBA 01/2017
1	mu Opioid Receptors (mu Opioid Receptor)IBA 12/2013
1	Morphine (MS Contin)FDA LinkGeneric 12/2013
1	RV-Jim-C3IBA 12/2013

Therapy/Procedure

1	Therapeutics 12/2013